News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,882 Results
Type
Article (8031)
Company Profile (140)
Press Release (476614)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166787)
Career Advice (305)
Deals (25746)
Drug Delivery (7)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8573)
News (238242)
Policy (17900)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33167)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10376)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3649)
Cardiovascular disease (217)
Career advice (247)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47870)
Collaboration (1246)
Commercialization (3)
Compensation (1468)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5654)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4210)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73758)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87637)
Executive appointments (702)
FDA (12389)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (918)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (951)
Grass and pollen (2)
Guidances (282)
Healthcare (9389)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (42)
IPO (12396)
IRA (2)
Job creations (1969)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5210)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14384)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3154)
Non-profit (847)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41259)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15467)
Phase 2 (21375)
Phase 3 (14401)
Pipeline (7323)
Policy (18)
Postmarket research (1572)
Preclinical (6540)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3021)
Recruiting (6)
Regulatory (14827)
Reports (21)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Last 7 days (219)
Last 30 days (1536)
Last 365 days (19005)
2026 (12305)
2025 (19258)
2024 (23001)
2023 (26563)
2022 (34596)
2021 (37183)
2020 (33468)
2019 (23275)
2018 (17484)
2017 (18771)
2016 (17923)
2015 (24264)
2014 (21681)
2013 (18138)
2012 (20222)
2011 (20449)
2010 (20332)
Location
Africa (229)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17890)
Australia (2099)
California (11987)
Canada (3147)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24728)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (700)
India (51)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7851)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5994)
Ohio (278)
Oklahoma (14)
Oregon (18)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (76)
South Dakota (1)
Southern California (4988)
Tennessee (120)
Texas (1940)
United States (38885)
Utah (360)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,882 Results for "mdxhealth inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
July 30, 2026
·
1 min read
Press Releases
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 2, 2026
·
5 min read
Press Releases
Mdxhealth Reports Q1-2026 Results
May 14, 2026
·
19 min read
Press Releases
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
April 30, 2026
·
1 min read
Press Releases
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results
February 27, 2026
·
15 min read
Press Releases
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
February 12, 2026
·
1 min read
Press Releases
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
March 16, 2026
·
8 min read
Press Releases
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
November 3, 2025
·
1 min read
Press Releases
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences
January 12, 2026
·
9 min read
Press Releases
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
January 6, 2026
·
6 min read
1 of 48,489
Next
